Quetiapine Fumarate Extended-Release Tablets, 150 mg, 100 tablets per unit dose carton, Rx only, ...

FDA Drug Recall #D-1000-2020 — Class III — February 27, 2020

Recall Summary

Recall Number D-1000-2020
Classification Class III — Low risk
Date Initiated February 27, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm The Harvard Drug Group
Location Livonia, MI
Product Type Drugs
Quantity 1 carton

Product Description

Quetiapine Fumarate Extended-Release Tablets, 150 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-6802-61

Reason for Recall

Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.

Distribution Pattern

Nationwide

Lot / Code Information

Lot, expiry: Lot N00036, exp 05/2021

Other Recalls from The Harvard Drug Group

Recall # Classification Product Date
D-0878-2023 Class II Tramadol Hydrochloride Tablets, USP 50 mg, Unit... Jun 16, 2023
D-0570-2023 Class III Gabapentin Tablets, USP 600 mg, packaged in Car... Apr 24, 2023
D-0432-2023 Class II Carbidopa and Levodopa Tablets, USP 25 mg/100 m... Feb 23, 2023
D-0649-2022 Class II PALIPERIDONE EXTENDED-RELEASE TABLETS, 9 mg, 10... Feb 28, 2022
D-0653-2022 Class II hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablet... Feb 24, 2022

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.